Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Maya Zlotnick"'
Publikováno v:
Acta Haematologica. 141:84-90
Gemcitabine-based salvage therapy is considered an effective treatment for relapsed and refractory Non-Hodgkin’s lymphoma (NHL). We analyzed the outcome of 41 consecutive NHL patients treated with gemcitabine-based regimens between January 2007 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::511f660fba34bff1c87c65e279e8607d
https://doi.org/10.1159/000495283
https://doi.org/10.1159/000495283
Autor:
Noga Shem-Tov, Abraham Avigdor, Meital Nagar, Avichai Shimoni, Chen Dor, Jonathan Canaani, Ronit Yerushalmi, Ivetta Danylesko, Maya Zlotnick, Kira Lozinsky, Ohad Benjamini, Arnon Nagler
Publikováno v:
European journal of haematologyREFERENCES. 106(2)
Background Relapsed/refractory acute myeloid leukemia (R/R AML) remains a significant therapeutic challenge and while meaningful therapeutics gains have been achieved with the introduction of novel agents, clinical outcomes remain unsatisfactory. Ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d38322c85d381cce4a639b0a465a82a7
https://pubmed.ncbi.nlm.nih.gov/33159365
https://pubmed.ncbi.nlm.nih.gov/33159365
Autor:
Maya Zlotnick, Elena Vasilev, Meirav Kedmi, Elena Ribakovsky, Guy Bitansky, Arnon Nagler, Ohad Benjamini, Abraham Avigdor
Publikováno v:
Leukemialymphoma. 61(11)
Progression of disease within 24 months of initial therapy (POD24) has previously been identified as a predictor of reduced overall survival (OS) for patients with follicular lymphoma (FL). Here we attempt to validate this finding in a retrospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::036210e341023f2b0d70f280ca4374ac
https://pubmed.ncbi.nlm.nih.gov/32643497
https://pubmed.ncbi.nlm.nih.gov/32643497
Autor:
Avichai Shimoni, Jonathan Canaani, Arnon Nagler, Abraham Avigdor, Naama Keren Froim, Gal Sharvit, Maya Zlotnick, Gabriel Heering
Publikováno v:
Blood. 138:3392-3392
Background. Early mortality remains a challenging therapeutic facet of the initial induction phase of intensive chemotherapy in patients with acute myeloid leukemia (AML). The impact of standard molecular evaluation and risk category of the European
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22cd2651e26fc0eece0edfd8a6b61281
https://doi.org/10.1182/blood-2021-145551
https://doi.org/10.1182/blood-2021-145551
Autor:
Gal Sharvit, Gabriel Heering, Maya Zlotnick, Arnon Nagler, Abraham Avigdor, Avichai Shimoni, Jonathan Canaani
Publikováno v:
Blood. 138:3390-3390
Background: Achievement of initial remission remains the most important clinical factor predicting long term survival in acute myeloid leukemia (AML) patients treated with intensive chemotherapy. Yet, whether the patient subset in need of a second cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9160fe5a30e1739303a32e461ef58500
https://doi.org/10.1182/blood-2021-145552
https://doi.org/10.1182/blood-2021-145552
Autor:
Simona Ben-Haim, Elinor Goshen, Y. Oksman, Ohad Benjamini, Maya Zlotnick, Abraham Avigdor, Tima Davidson, Ella Nissan, Johnatan Nissan, Bar Chikman
Publikováno v:
Clinical lymphoma, myelomaleukemia. 20(4)
Background The value of positron emission tomography/computed tomography (PET/CT) in the staging and assessment of treatment response in marginal zone lymphoma (MZL) lymphomas remains controversial. We investigated radiologic characteristics of subcu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ec131fdc92b50ae5ae1adfab072039d
https://pubmed.ncbi.nlm.nih.gov/32115401
https://pubmed.ncbi.nlm.nih.gov/32115401
Autor:
Maya Zlotnick, Ronit Yerushalmi, Arnon Nagler, Joshua A Fein, Ivetta Danylesko, Noga Shem-Tov, Aniela Shouval, Roni Shouval, Avichai Shimoni
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S70-S71
Background Prediction of clinical outcomes following allogeneic hematopoietic stem cell transplantation (Allo-HSCT) may promote informed decisions and treatment personalization. We sought to evaluate the predictive performance of six commonly used mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3735b943aee499a43768c9ac738055d
https://doi.org/10.1016/j.bbmt.2018.12.156
https://doi.org/10.1016/j.bbmt.2018.12.156
Autor:
Elena Ribakovsky, Ohad Benjamini, Meirav Kedmi, Arnon Nagler, Elena Vasilev, Guy Bitansky, Maya Zlotnick, Abraham Avigdor
Publikováno v:
Blood. 134:1534-1534
Background: Follicular lymphoma (FL) is the most common indolent lymphoma in the western world with a median survival approaching 20 years. However, the course of the disease is extremely heterogeneous and therefore, at diagnosis it is difficult to p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1610ca99a5e7c97ff98af13c3e9fc788
https://doi.org/10.1182/blood-2019-125218
https://doi.org/10.1182/blood-2019-125218
Autor:
Drorit Merkel, Merav Leiba, Elena Ribakovsky, Arnon Nagler, Avichai Shimoni, Noga Shem-Tov, Maya Zlotnick, Ronit Yerushalmi, Ohad Benjamini, Yulia Volchek, Abraham Avigdor, Meirav Kedmi, Adrian Duek, Ivetta Danylesko
Publikováno v:
Blood. 128:5429-5429
Background: Immunosuppressive therapy is a known risk factor for hepatits B reactivation. The highest risk is reported in hematologic patients treated with anti-CD20 monoclonal antibodies, glucocorticoids and hematopoietic stem cell transplantation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45131ac29ed8aea9111ce8c5f7810b8c
https://doi.org/10.1182/blood.v128.22.5429.5429
https://doi.org/10.1182/blood.v128.22.5429.5429